» Articles » PMID: 18589867

Histopathologic Findings and Establishment of Novel Tumor Lines from Spontaneous Tumors in FVB/N Mice

Overview
Journal Comp Med
Specialty General Medicine
Date 2008 Jul 1
PMID 18589867
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

The inbred FVB mouse strain is used extensively in cancer research. Transgenic mice with an FVB/N background in which the expression of green fluorescent protein is under the control of various promoters have been used widely for the last decade. However, little is known about the incidence and characteristics of spontaneous tumors in these mice. In addition, only a few tumor lines have been established for use in this particular mouse strain. Our aim was to initiate a database of spontaneous tumors in our retired FVB/N breeders, analyze the histopathologic characteristics of these tumors, and establish novel tumor lines in vivo and in vitro. A total of 234 (40 male, 194 female) breeder mice were observed during their natural lifespans. The incidence of spontaneous tumors was 45.0% in male mice and 52.8% in female mice. All tumors in male mice were lung alveolar-bronchiolar (AB) neoplasms, except for 1 testis interstitial cell tumor. In female mice, histopathologic examination revealed 48 lung AB tumors, 27 mammary gland tumors, 13 ovarian tumors, and 14 other tumors. Several of these spontaneous tumors have been transplanted into FVB/N mice. One mammary adenocarcinoma (MCaP0008) and 1 lung AB carcinoma (LAP0297) were successfully transplanted subcutaneously and passaged serially in vivo. Subsequently, we established cell lines from both tumors, which were maintained in monolayer in vitro. Both of the grafted tumors and cell lines are tumorigenic in VEGF(P)-GFP/FVB and Tie2(P)-GFP/FVB mice. Establishment of these novel tumor lines will benefit both in vivo and in vitro studies on the pathophysiology of cancer in this relatively new but widely used mouse strain.

Citing Articles

High baseline levels of PD-L1 reduce the heterogeneity of immune checkpoint signature and sensitize anti-PD1 therapy in lung and colorectal cancers.

Fan P, Qi Z, Liu Z, Wang S, Wang Y, Kuai J Cell Death Dis. 2025; 16(1):152.

PMID: 40038236 PMC: 11880386. DOI: 10.1038/s41419-025-07471-w.


Bayesian analysis of the rate of spontaneous malignant mesothelioma among BAP1 mutant mice in the absence of asbestos exposure.

Nielsen D, Hsu M, Zapata 3rd M, Ciavarra G, van Zyl L Sci Rep. 2025; 15(1):169.

PMID: 39747518 PMC: 11697272. DOI: 10.1038/s41598-024-84069-w.


Betaglycan sustains HGF/Met signaling in lung cancer and endothelial cells promoting cell migration and tumor growth.

Cervantes-Villagrana R, Mendoza V, Hinck C, de la Fuente-Leon R, Hinck A, Reyes-Cruz G Heliyon. 2024; 10(9):e30520.

PMID: 38756586 PMC: 11096750. DOI: 10.1016/j.heliyon.2024.e30520.


Isolation and Characterization of a Novel Mammary Adenocarcinoma, MCa-P1362, with Hormone Receptor Expression, Human Epidermal Growth Factor Receptor 2 Positivity, and Enrichment in Cancer and Mesenchymal Stem Cells.

Jana S, Li W, Lei P, Wang Z, Kibara S, Huang P Am J Pathol. 2024; 194(6):1137-1153.

PMID: 38749609 PMC: 11156160. DOI: 10.1016/j.ajpath.2024.02.013.


Lentinan enhances the antitumor effects of Delta-like 1 via neutrophils.

Xu H, Qi Z, Zhao Q, Xue J, Zhu J, He Y BMC Cancer. 2022; 22(1):918.

PMID: 36008793 PMC: 9414423. DOI: 10.1186/s12885-022-10011-w.


References
1.
Huang P, Allam A, Taghian A, Freeman J, Duffy M, Suit H . Growth and metastatic behavior of five human glioblastomas compared with nine other histological types of human tumor xenografts in SCID mice. J Neurosurg. 1995; 83(2):308-15. DOI: 10.3171/jns.1995.83.2.0308. View

2.
Padera T, Stoll B, So P, Jain R . Conventional and high-speed intravital multiphoton laser scanning microscopy of microvasculature, lymphatics, and leukocyte-endothelial interactions. Mol Imaging. 2003; 1(1):9-15. DOI: 10.1162/15353500200200004. View

3.
Schlaeger T, Bartunkova S, Lawitts J, TEICHMANN G, Risau W, Deutsch U . Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice. Proc Natl Acad Sci U S A. 1997; 94(7):3058-63. PMC: 20321. DOI: 10.1073/pnas.94.7.3058. View

4.
Duda D, Fukumura D, Munn L, Booth M, Brown E, Huang P . Differential transplantability of tumor-associated stromal cells. Cancer Res. 2004; 64(17):5920-4. DOI: 10.1158/0008-5472.CAN-04-1268. View

5.
Fukumura D, Xavier R, Sugiura T, Chen Y, Park E, Lu N . Tumor induction of VEGF promoter activity in stromal cells. Cell. 1998; 94(6):715-25. DOI: 10.1016/s0092-8674(00)81731-6. View